The reaction of Ln(III) ions with a tripodal ligand HBpz(3)(-) (hydrotris(pyrazol-1-yl)borate) and a "complex ligand" [Cr(acac)(2)(ox)](-) (acac(-) = acetylacetonate, ox(2)(-) = oxalate) in aqueous solution afforded a series of the novel 3d-4f heterodinuclear complexes [(acac)(2)Cr(ox)Ln(HBpz(3))(2)] (Ln = Eu (1), Gd (2), Tb (3), Yb (4), Lu (5)). The crystal structure of 4 has been determined by X-ray diffraction. Complex 4 crystallizes in monoclinic space group P2/n, of which the cell parameters are a = 8.594(3) Å, b = 18.538(4) Å, c = 12.093(2) Å, beta = 93.71(2) degrees, and Z = 2. The Yb atom has an eight-coordinate distorted square antiprismatic coordination geometry. The intramolecular Cr.Yb distance is 5.631(1) Å. The magnetic susceptibility data for complex 2 showed that the Cr(III)-Gd(III) interaction is weakly antiferromagnetic with an exchange coupling constant J(CrGd) = -0.09 cm(-)(1). The luminescence measurements demonstrated the energy transfers for both Ln(III) --> Cr(III) and Cr(III) --> Ln(III), of which the degree of emission quenching depends on the energy gap of the excited levels in two metal centers. These results reveal that the metal-metal interactions between Cr(III) and Ln(III) are very weak in magnetic interaction but are strong from the viewpoint of energy transfer.
No takes yet. Share an insight, caveat, or question.
Sanada et al. (1998) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: